Total Payments
$4,695
2024 Payments
$1,264
Companies
37
Transactions
319
Medicare Patients
688
Medicare Billing
$50,568
Payment Breakdown by Category
Food & Beverage$4,695 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,695 | 319 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,078 | 98 | $0 (2024) |
| GlaxoSmithKline, LLC. | $532.06 | 36 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $419.60 | 31 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $403.12 | 18 | $0 (2024) |
| Lilly USA, LLC | $269.22 | 16 | $0 (2024) |
| Novo Nordisk Inc | $251.91 | 20 | $0 (2023) |
| PFIZER INC. | $221.42 | 12 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $220.46 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $131.96 | 9 | $0 (2023) |
| Abbott Laboratories | $121.37 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,264 | 73 | GlaxoSmithKline, LLC. ($239.30) |
| 2023 | $1,166 | 82 | ABBVIE INC. ($364.99) |
| 2022 | $1,001 | 76 | ABBVIE INC. ($182.96) |
| 2021 | $1,264 | 88 | AbbVie Inc. ($327.09) |
All Payment Transactions
319 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Diabetes Care | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Diabetes Care | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| Category: Cardiovascular | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: Opioid Analgesic | ||||||
| 10/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: UROLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: VACCINES | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 166 | 220 | $40,429 | $13,661 |
| 2022 | 4 | 146 | 183 | $34,482 | $11,876 |
| 2021 | 5 | 179 | 228 | $38,536 | $12,786 |
| 2020 | 7 | 197 | 233 | $39,968 | $12,245 |
Total Patients
688
Total Services
864
Medicare Billing
$50,568
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 126 | $25,956 | $8,402 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $4,750 | $1,949 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 19 | $4,579 | $1,904 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 28 | $3,920 | $1,159 | 29.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 16 | $576.00 | $137.47 | 23.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $648.00 | $108.39 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 108 | $22,248 | $7,153 | 32.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $7,250 | $3,062 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 32 | $4,480 | $1,526 | 34.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 14 | $504.00 | $134.41 | 26.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 113 | $23,278 | $7,615 | 32.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 65 | $9,100 | $2,646 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $5,000 | $2,160 | 43.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $546.00 | $205.68 | 37.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 14 | 17 | $612.00 | $159.03 | 26.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 109 | $22,454 | $6,104 | 27.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 25 | 25 | $6,250 | $2,343 | 37.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 43 | $6,020 | $1,741 | 28.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 12 | $2,892 | $955.28 | 33.0% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 12 | $1,116 | $707.40 | 63.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 13 | 14 | $588.00 | $220.34 | 37.5% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 17 | 18 | $648.00 | $174.40 | 26.9% |
About David Sepulveda, PA-C
David Sepulveda, PA-C is a Surgical healthcare provider based in Gonzales, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1316100381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Sepulveda, PA-C has received a total of $4,695 in payments from pharmaceutical and medical device companies, with $1,264 received in 2024. These payments were reported across 319 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,695).
As a Medicare-enrolled provider, Sepulveda has provided services to 688 Medicare beneficiaries, totaling 864 services with total Medicare billing of $50,568. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical
- Location Gonzales, LA
- Active Since 07/09/2008
- Last Updated 04/07/2021
- Taxonomy Code 363AS0400X
- Entity Type Individual
- NPI Number 1316100381
Products in Payments
- VRAYLAR (Drug) $590.09
- TRINTELLIX (Drug) $381.28
- UBRELVY (Drug) $367.50
- TRELEGY ELLIPTA (Drug) $366.04
- JARDIANCE (Drug) $241.08
- Kerendia (Drug) $220.46
- ELIQUIS (Drug) $147.73
- MOUNJARO (Drug) $134.82
- TRULICITY (Drug) $134.40
- STIOLTO RESPIMAT (Drug) $125.51
- QULIPTA (Drug) $120.37
- AREXVY (Drug) $108.22
- FREESTYLE LIBRE 3 (Device) $103.92
- XARELTO (Drug) $103.17
- Auvelity (Drug) $95.24
- Ozempic (Drug) $81.67
- NALOCET (Drug) $76.37
- BELSOMRA (Drug) $73.51
- COLOGUARD DNA CAPTURE REAGENTS (Device) $72.93
- NURTEC ODT (Drug) $69.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.